Addex Therapeutics (ADXN) Return on Sales (2022 - 2025)
Historic Return on Sales for Addex Therapeutics (ADXN) over the last 4 years, with Q3 2025 value amounting to 11.46%.
- Addex Therapeutics' Return on Sales fell 114100.0% to 11.46% in Q3 2025 from the same period last year, while for Sep 2025 it was 11.46%, marking a year-over-year decrease of 179200.0%. This contributed to the annual value of 29.61% for FY2024, which is 346000.0% up from last year.
- Per Addex Therapeutics' latest filing, its Return on Sales stood at 11.46% for Q3 2025, which was down 114100.0% from 20.2% recorded in Q2 2025.
- Addex Therapeutics' Return on Sales' 5-year high stood at 124.66% during Q2 2024, with a 5-year trough of 52.5% in Q4 2023.
- In the last 4 years, Addex Therapeutics' Return on Sales had a median value of 10.07% in 2024 and averaged 4.87%.
- As far as peak fluctuations go, Addex Therapeutics' Return on Sales surged by 1280700bps in 2024, and later plummeted by -1448600bps in 2025.
- Over the past 4 years, Addex Therapeutics' Return on Sales (Quarter) stood at 10.72% in 2022, then tumbled by -590bps to 52.5% in 2023, then soared by 80bps to 10.55% in 2024, then fell by -9bps to 11.46% in 2025.
- Its Return on Sales was 11.46% in Q3 2025, compared to 20.2% in Q2 2025 and 16.33% in Q1 2025.